Capstone Investment Advisors
GILD icon

Capstone Investment Advisors’s Gilead Sciences GILD Stock Holding History

Capstone Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.86M Buy
20,500
+8,700
+74% +$1.22M 0.01% 549
2025
Q4 		$1.45M Sell
11,800
-21,400
-64% -$2.6M ﹤0.01% 725
2025
Q3 		$3.69M Sell
33,200
-4,900
-13% -$557K 0.01% 567
2025
Q2 		$4.22M Sell
38,100
-18,000
-32% -$1.92M 0.01% 423
2025
Q1 		$6.29M Sell
56,100
-4,300
-7% -$444K 0.02% 398
2024
Q4 		$5.58M Buy
60,400
+3,300
+6% +$297K 0.01% 510
2024
Q3 		$4.79M Buy
57,100
+5,900
+12% +$450K 0.01% 472
2024
Q2 		$3.51M Buy
51,200
+17,900
+54% +$1.19M 0.01% 552
2024
Q1 		$2.44M Sell
33,300
-20,700
-38% -$1.59M 0.01% 694
2023
Q4 		$4.37M Buy
54,000
+25,400
+89% +$1.98M 0.01% 575
2023
Q3 		$2.14M Sell
28,600
-10,300
-26% -$792K 0.01% 705
2023
Q2 		$3M Buy
38,900
+2,400
+7% +$191K 0.01% 521
2023
Q1 		$3.03M Buy
36,500
+33,200
+1,006% +$2.75M 0.02% 482
2022
Q4 		$283K Sell
3,300
-14,500
-81% -$1.15M ﹤0.01% 1228
2022
Q3 		$1.1M Sell
17,800
-1,500
-8% -$94.6K 0.01% 968
2022
Q2 		$1.19M Sell
19,300
-64,900
-77% -$4.02M 0.01% 951
2022
Q1 		$5.01M Sell
84,200
-145,600
-63% -$9.31M 0.01% 705
2021
Q4 		$16.7M Sell
229,800
-129,800
-36% -$8.94M 0.03% 476
2021
Q3 		$25.1M Buy
359,600
+11,100
+3% +$780K 0.05% 358
2021
Q2 		$24M Sell
348,500
-12,400
-3% -$828K 0.05% 310
2021
Q1 		$23.3M Buy
360,900
+84,900
+31% +$5.47M 0.07% 264
2020
Q4 		$16.1M Buy
276,000
+64,000
+30% +$3.86M 0.05% 290
2020
Q3 		$13.4M Buy
212,000
+107,600
+103% +$7.46M 0.07% 246
2020
Q2 		$8.03M Buy
104,400
+101,700
+3,767% +$7.79M 0.05% 308
2020
Q1 		$202K Sell
2,700
-230,900
-99% -$16M ﹤0.01% 1017
2019
Q4 		$15.2M Buy
233,600
+53,400
+30% +$3.48M 0.08% 253
2019
Q3 		$11.4M Buy
180,200
+33,400
+23% +$2.18M 0.08% 255
2019
Q2 		$9.92M Buy
146,800
+56,000
+62% +$3.68M 0.07% 291
2019
Q1 		$5.9M Buy
90,800
+37,600
+71% +$2.5M 0.05% 314
2018
Q4 		$3.33M Sell
53,200
-14,300
-21% -$1,000K 0.04% 334
2018
Q3 		$5.21M Buy
67,500
+63,800
+1,724% +$4.82M 0.06% 244
2018
Q2 		$262K Buy
+3,700
New +$261K ﹤0.01% 551
2018
Q1 		– Sell
-1,000
Closed -$71K – 424
2017
Q4 		$71K Hold
1,000
– – ﹤0.01% 469
2017
Q3 		$81K Hold
1,000
– – ﹤0.01% 507
2017
Q2 		$70K Sell
1,000
-4,300
-81% -$286K ﹤0.01% 603
2017
Q1 		$356K Hold
5,300
– – 0.01% 669
2016
Q4 		$377K Buy
+5,300
New +$394K 0.01% 671
2015
Q2 		– Sell
-100,000
Closed -$9.81M – 303
2015
Q1 		$9.81M Buy
100,000
+15,000
+18% +$1.52M 0.16% 116
2014
Q4 		$8.01M Buy
+85,000
New +$8.79M 0.11% 126
2014
Q2 		– Sell
-3,100
Closed -$219K – 423
2014
Q1 		$219K Buy
+3,100
New +$243K ﹤0.01% 354

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capstone Investment Advisors's GILD Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Gilead Sciences (GILD) in Q1 2026: 6,254 shares worth $872K. The stake represents ﹤0.01% of the portfolio and ranks #906 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in GILD as recently as Q3 2025.

Capstone Investment Advisors first reported a position in GILD in Q1 2014 and has held it in 36 quarters since. The position peaked at $13.9M in Q1 2022. 2,312 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Capstone Investment Advisors held 6,254 shares of Gilead Sciences worth $872K as of Q1 2026.
  • Gilead Sciences was a new Capstone Investment Advisors position in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #906 holding.
  • Capstone Investment Advisors first reported a position in Gilead Sciences in Q1 2014 and has held it in 36 quarters since.
  • Capstone Investment Advisors's Gilead Sciences position peaked at $13.9M in Q1 2022.
  • 2,312 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.